Synthesis of Bioerodible Poly(ε-caprolactone) Latexes and Poly(D, L-lactide) Microspheres by Ring-Opening Polymerization

  • S. Sosnowski
    Polish Academy of Sciences Center of Molecular and Macromolecular Studies Department of Polymer Chemistry Sienkiewicza 112 90-363 Lodz, Poland
  • M. Gadzinowski
    Polish Academy of Sciences Center of Molecular and Macromolecular Studies Department of Polymer Chemistry Sienkiewicza 112 90-363 Lodz, Poland
  • S. Slomkowski
    Polish Academy of Sciences Center of Molecular and Macromolecular Studies Department of Polymer Chemistry Sienkiewicza 112 90-363 Lodz, Poland
  • S. Penczek
    Polish Academy of Sciences Center of Molecular and Macromolecular Studies Department of Polymer Chemistry Sienkiewicza 112 90-363 Lodz, Poland

抄録

<jats:p> Poly(ε-caprolactone) [poly(CL)] latexes and poly(D,L-lactide) [poly(D,L-Lc)] microspheres were prepared directly by ring-opening precipita tion polymerization carried out in heptane-dioxane (4:1 v/v) mixed solvent in the presence of poly(dodecyl acrylate)-g-poly(ε-caprolactone) used as the surface active agent. This designed synthetic method yielded latexes and microspheres with narrow size distribution; poly(CL) latex D<jats:sub>v</jats:sub>/D<jats:sub>n</jats:sub> = 1.038 and for poly(D,L- Lc) microspheres D<jats:sub>v</jats:sub>/D<jats:sub>n</jats:sub> = 1.15. (D<jats:sub>v</jats:sub> and D<jats:sub>n</jats:sub> denote the volume and number average diameters of particles.) The poly(CL) latex, synthesized by using CH<jats:sub>3</jats:sub>CH<jats:sub>2</jats:sub>OAl(CH<jats:sub>2</jats:sub>CH<jats:sub>3</jats:sub>)<jats:sub> 2</jats:sub> as initiator, had a narrow polymer polydispersity of 1.11. Poly(D,L-Lc) microspheres, besides polymer with M<jats:sub>w</jats:sub>/M<jats:sub> n</jats:sub> = 1.05 contained some unreacted lactide. Adsorption of human serum albumin and human gamma globulins on both kinds of polyester particles was studied for their potential use as polypeptide and protein delivery systems. </jats:p>

収録刊行物

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ